Monday, September 14, 2026
RSS

Markets & Money

Kimberly-Clark (KMB) and Kenvue (KVUE) Deal Faces EU Scrutiny: An Investor's Perspective

Kimberly-Clark is making concessions for EU approval of its $40B acquisition of Kenvue amid regulatory scrutiny.

By Marcus Rivera • September 14, 2026
Pharmaceutical

Scholar Rock (SRRK) Gains Momentum After FDA Approval: What It Means for Investors

Scholar Rock's stock gains traction following FDA approval of ISEMBYLD, prompting Truist to raise its price target.

Sarah Chen • Sep 14
Markets & Money

Baldwin Group's Strategic Shift to Go Private: Implications for Shareholders

Baldwin Group, Inc. will go private through a strategic acquisition, raising questions for its shareholders.

Marcus Rivera • Sep 14
Trade with the conviction of the 1%.

Institutional-grade market intelligence delivered before the opening bell.

By subscribing, I agree to receive marketing emails and alerts. View our Privacy Policy. You may unsubscribe at any time.

More Stories
Pharmaceutical

Definium Therapeutics' Phase 3 Trial Success: A 20% Surge That Investors Can't Ignore

Definium Therapeutics' shares surged 20% after positive Phase 3 trial results, indicating strong market potential amid b…

Sarah Chen • Sep 14, 2026
Pharmaceutical

BioNTech's Gotistobart Drug Boosts Lung Cancer Survival Rates: A Game-Changer for Investors

BioNTech's gotistobart shows promise in lung cancer trials, driving a 6.4% premarket stock rise amid broader market decl…

James McAllister • Sep 14, 2026
Pharmaceutical

Canadian Healthcare Budgets Under Pressure: Implications for Pharmaceutical Investors

New cancer drugs are straining Canadian healthcare budgets, raising concerns for investors in the pharmaceutical sector.

Marcus Rivera • Sep 13, 2026
Energy

Oil Prices Surge: What It Means for North American Energy Investors

U.S. crude oil prices exceed $102 per barrel, raising questions for energy investors amid geopolitical tensions.

Sarah Chen • Sep 13, 2026
Tech

Oracle's Restructuring Costs: Implications for Investors and Market Dynamics

Oracle's restructuring costs have surged to $2.8 billion, raising concerns about its market competitiveness and earnings…

James McAllister • Sep 13, 2026
Pharmaceutical

Activist Investor Backs Seraxis Takeover of Sernova: Implications for the Canadian Biotech Sector

A shareholder's support for Seraxis's takeover of Sernova signals potential shifts in the Canadian biotech landscape.

Marcus Rivera • Sep 12, 2026
Pharmaceutical

FDA Delays Exelixis' Zanzalintinib Review: What It Means for Investors

The FDA's delay in reviewing Exelixis' zanzalintinib raises questions for investors about future revenue and growth.

Sarah Chen • Sep 12, 2026
Energy

Crude Oil Prices Surge Past $102: Implications for US and Canadian Energy Markets

Crude oil prices have surpassed $102, driven by geopolitical tensions and supply concerns, impacting US and Canadian ene…

James McAllister • Sep 12, 2026
Markets & Money

Consumer Sentiment Plummets as Inflation Fears Rise, Potential Fed Rate Hike Looms

Consumer sentiment drops to 47.8, sparking inflation concerns and signaling possible Fed interest rate hikes.

Marcus Rivera • Sep 11, 2026